Tag: Pfizer/BioNTech

Pfizer and BioNTech applied to the Food and Drug Administration (FDA) for full approval of their COVID-19 vaccine.  More than 134 million doses of Pfizer’s vaccine have already been administered across the U.S. under an emergency use authorization (EUA), according to the Centers for Disease Control and Prevention (CDC). Similarly, more than 109 million doses

With a strategic alliance, 24-hour production and a bit of luck, Pfizer and BioNTech were able to roll out their COVID vaccine at a brisk pace and relatively free of controversy. US pharmaceutical giant Pfizer and BioNTech, a smaller German biotech firm, joined forces on April 9, 2020, as the world reeled from the pandemic,